These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease. Taylor LM; DeFrang RD; Harris EJ; Porter JM J Vasc Surg; 1991 Jan; 13(1):128-36. PubMed ID: 1987384 [TBL] [Abstract][Full Text] [Related]
5. Patients with atherosclerotic vascular disease: how low should plasma homocyst(e)ine levels go? Spence JD Am J Cardiovasc Drugs; 2001; 1(2):85-9. PubMed ID: 14728038 [TBL] [Abstract][Full Text] [Related]
6. Homocyst(e)ine: an important risk factor for atherosclerotic vascular disease. Duell PB; Malinow MR Curr Opin Lipidol; 1997 Feb; 8(1):28-34. PubMed ID: 9127708 [TBL] [Abstract][Full Text] [Related]
7. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. Malinow MR; Duell PB; Hess DL; Anderson PH; Kruger WD; Phillipson BE; Gluckman RA; Block PC; Upson BM N Engl J Med; 1998 Apr; 338(15):1009-15. PubMed ID: 9535664 [TBL] [Abstract][Full Text] [Related]
9. Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study. Malinow MR; Nieto FJ; Szklo M; Chambless LE; Bond G Circulation; 1993 Apr; 87(4):1107-13. PubMed ID: 8462139 [TBL] [Abstract][Full Text] [Related]
10. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. Coull BM; Malinow MR; Beamer N; Sexton G; Nordt F; de Garmo P Stroke; 1990 Apr; 21(4):572-6. PubMed ID: 2326839 [TBL] [Abstract][Full Text] [Related]
11. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Verhoef P; Stampfer MJ; Buring JE; Gaziano JM; Allen RH; Stabler SP; Reynolds RD; Kok FJ; Hennekens CH; Willett WC Am J Epidemiol; 1996 May; 143(9):845-59. PubMed ID: 8610698 [TBL] [Abstract][Full Text] [Related]
12. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease. Manns BJ; Burgess ED; Hyndman ME; Parsons HG; Schaefer JP; Scott-Douglas NW Am J Kidney Dis; 1999 Oct; 34(4):669-77. PubMed ID: 10516348 [TBL] [Abstract][Full Text] [Related]
13. Vitamin intake: a possible determinant of plasma homocyst(e)ine among middle-aged adults. Shimakawa T; Nieto FJ; Malinow MR; Chambless LE; Schreiner PJ; Szklo M Ann Epidemiol; 1997 May; 7(4):285-93. PubMed ID: 9177112 [TBL] [Abstract][Full Text] [Related]
14. Plasma homocyst(e)ine levels in men with premature coronary artery disease. Genest JJ; McNamara JR; Salem DN; Wilson PW; Schaefer EJ; Malinow MR J Am Coll Cardiol; 1990 Nov; 16(5):1114-9. PubMed ID: 2229757 [TBL] [Abstract][Full Text] [Related]
15. [Hyperhomocysteinemia, a risk factor for atherosclerosis: causes and effects]. Weiss N; Pietrzik K; Keller C Dtsch Med Wochenschr; 1999 Sep; 124(38):1107-13. PubMed ID: 10535040 [No Abstract] [Full Text] [Related]
16. Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease. Kang SS; Wong PW; Cook HY; Norusis M; Messer JV J Clin Invest; 1986 May; 77(5):1482-6. PubMed ID: 3700650 [TBL] [Abstract][Full Text] [Related]
17. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Eikelboom JW; Lonn E; Genest J; Hankey G; Yusuf S Ann Intern Med; 1999 Sep; 131(5):363-75. PubMed ID: 10475890 [TBL] [Abstract][Full Text] [Related]